China's Internet Platform for Primary Medical Service Yunhu Technology Secures Tens of Millions RMB in Series A+ Financing

HANGZHOU,China,March 13,2019 -- Yunhu Technology,an internet platform for primary medical service in China,announced that it has secured tens of millions RMB in series A+ financing,led by China Creation Ventures and joined by existing backers including Vision+ Capital,Morningside Venture Capital,Cash Capital and BioTrack Capital. China Renaissance's Alpha team is the exclusive financial consultant for this round of financing.

The Hangzhou-based business was founded in 2017 and aims to make medical examination and diagnosis available to everyone,and has created China's first internet platform for medical examination that connects more than a thousand local medical institutions.

The company has the following three major product lines: a series of Platform-based Testing Products which is highly comprehensive and authoritative; a SaaS based LISHIS platform which is designed for local medication institution to use; and a 3rd party cold chain logistic to support the efficient blood/drug delivery.

Yunhu Technology's founder Xiaobin Chen commented: "The huge gap between the demand and supply in China's healthcare resources has been a long term issue. We are aiming to break the gap between the healthcare services quality from the countryside and the cities; therefore,to provide an equal healthcare environment for every family in this country."

The company counts more than 800 employees across its offices in Beijing,Shanghai,and Hangzhou.

It previously got a pre-Series A round investment from Vision+ Capital and Morningside Venture Capital,and took on RMB 8 million from Cash Capital and RMB 30 million from BioTrack Capital in Series A round financing.